Description

6H-Indazol-6-One,7-(Diaminomethylene)-2,4,5,7-Tetrahydro-(9Ci) is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated molecular scaffolds. It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in drug discovery and process development.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of complex drug candidates, especially those targeting neurological and oncological pathways.
• Organic Synthesis Building Block: Used in research laboratories for constructing novel heterocyclic compounds and exploring new chemical spaces.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and the development of new molecular entities.
• Process Chemistry Development: Employed in scaling up synthetic routes from laboratory to pilot plant and commercial manufacturing scales.
• Biochemical Research: Potential use as a tool compound or probe in biochemical assays and target validation studies.

Basic Information

Product Name	6H-Indazol-6-One,7-(Diaminomethylene)-2,4,5,7-Tetrahydro-(9Ci)
CAS No.	174841-69-1
Molecular Formula	C8H8N4O
Molecular Weight	176.18 g/mol
Synonyms	7-(Diaminomethylene)-2,4,5,7-tetrahydro-6H-indazol-6-one; 7-(Diaminomethylene)-2,4,5,7-tetrahydro-6H-indazol-6-one (9CI); 174841-69-1; 7-(Diaminomethylene)-2,4,5,7-tetrahydro-6H-indazol-6-one; 6H-Indazol-6-one, 7-(diaminomethylene)-2,4,5,7-tetrahydro-; 7-(Diaminomethylene)-2,4,5,7-tetrahydro-1H-indazol-6-one; 7-(Diaminomethylene)-2,4,5,7-tetrahydro-1H-indazol-6-one (non-preferred tautomer).
EINECS	Contact for details

Quality Control

Our 6H-Indazol-6-One,7-(Diaminomethylene)-2,4,5,7-Tetrahydro-(9Ci) is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the stringent requirements for pharmaceutical R&D. Certificates of Analysis (COA) with detailed specifications are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.